These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2862956)

  • 1. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats.
    Mereu G; Casu M; Gessa GL
    Brain Res; 1983 Mar; 264(1):105-10. PubMed ID: 6133578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.
    Zivkovic B; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):193-200. PubMed ID: 629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.
    Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Jun; 830(2):237-45. PubMed ID: 10366680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
    Berry SA; Gudelsky GA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats.
    Windels F; Kiyatkin EA
    Eur J Neurosci; 2006 Sep; 24(5):1385-94. PubMed ID: 16987223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
    Cruz CJ; Beckstead RM
    Brain Res; 1988 Aug; 457(1):29-43. PubMed ID: 2458801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of acute and chronic treatment with SCH 23390 on the spontaneous activity of midbrain dopamine neurons.
    Esposito E; Bunney BS
    Eur J Pharmacol; 1989 Mar; 162(1):109-13. PubMed ID: 2656273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
    Murrin LC; Roth RH
    Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.